Caeley Reever MS

Caeley Reever, MS, is a biotechnology entrepreneur and scientist focused on advancing innovative therapeutics through translational research and drug development. She is the Co-Founder and Chief Scientific Officer of Stellula Therapeutics, where she leads scientific strategy and research initiatives aimed at developing next-generation therapies for complex diseases.

Caeley completed her Master’s degree in Biological and Physical Sciences at the University of Virginia School of Medicine and continued her academic training there as a PhD candidate. Her research background combines molecular biology, biomedical science, and translational medicine, with a strong emphasis on bridging foundational research and therapeutic application.

With expertise spanning experimental design, scientific leadership, and early-stage biotech development, she works at the intersection of academic science and therapeutic innovation to accelerate the translation of cutting-edge discoveries into impactful clinical solutions.